{"organizations": [], "uuid": "1a4492e865c3fe0a2a043d6a543d0177cf72006b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fda-ftc-warn-companies-for-selling/brief-fda-ftc-warn-companies-for-selling-illegal-unapproved-opioid-cessation-products-using-deceptive-claims-idUSFWN1PJ0WK", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA, FTC Warn Companies For Selling Illegal, Unapproved Opioid Cessation Products Using Deceptive Claims", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.938, "site_type": "news", "published": "2018-01-24T23:15:00.000+02:00", "replies_count": 0, "uuid": "1a4492e865c3fe0a2a043d6a543d0177cf72006b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fda-ftc-warn-companies-for-selling/brief-fda-ftc-warn-companies-for-selling-illegal-unapproved-opioid-cessation-products-using-deceptive-claims-idUSFWN1PJ0WK", "ord_in_thread": 0, "title": "BRIEF-FDA, FTC Warn Companies For Selling Illegal, Unapproved Opioid Cessation Products Using Deceptive Claims", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "u.s. food and drug administration", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "ftc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24 (Reuters) - U.S. Food and Drug Administration:\n* FDA, FTC WARN COMPANIES FOR SELLING “ILLEGAL, UNAPPROVED OPIOID CESSATION PRODUCTS USING DECEPTIVE CLAIMS”\n* U.S. FDA SAYS FDA, AND THE FEDERAL TRADE COMMISSION ON JAN 24 POSTED JOINT WARNING LETTERS TO MARKETERS, DISTRIBUTORS OF 12 OPIOID CESSATION PRODUCTS‍​\n* ‍U.S FDA - LETTERS SENT TO COS SELLING UNAPPROVED OPIOID CESSATION PRODUCTS STATE THAT FAILURE TO CORRECT VIOLATIONS MAY RESULT IN LAW ENFORCEMENT ACTION Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T23:15:00.000+02:00", "crawled": "2018-01-25T13:26:08.009+02:00", "highlightTitle": ""}